Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0778
+0.0074 (10.51%)
Oct 16, 2026, 4:41 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 95.5 million as of October 16, 2026. It is the 40,043rd most valuable company in the world and the 110th biggest in Denmark. Its market cap has decreased by 22.04% in one year.
Market Cap
95.50M
Enterprise Value
106.22M
Revenue
n/a
Global Rank
Country Rank
#110 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 95.50M, a decrease of -87.55%. That is a compound annual growth rate of -44.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 95.50M | -16.70% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.15T |
| Genmab | 149.50B |
| Coloplast | 106.32B |
| Demant | 75.67B |
| Gubra | 4.85B |
| BioPorto | 519.86M |
| ViroGates | 76.58M |
| Scandinavian Medical Solutions | 66.46M |